ChannelAdvisor says eBay sales up 57 percent early on Cyber Monday

(Reuters) – ChannelAdvisor said client sales on eBay Inc‘s online marketplace jumped 57 percent from a year before early on Cyber Monday.

The sales growth rate was five times higher than during the same period last year, said ChannelAdvisor, which helps merchants sell more on websites including Amazon.com Inc and eBay.com.

Client sales on Amazon.com were up 52 percent during the first part of Cyber Monday, ChannelAdvisor also reported.

(Reporting By Alistair Barr; Editing by Gerald E. McCormick)

Internet News Headlines – Yahoo! News

Read More..

Actor: CBS comedy 'Two and a Half Men' is 'filth'

NEW YORK (AP) — The teenage actor who plays the half in the hit CBS comedy "Two and a Half Men" says it's "filth" and through a video posted by a Christian church has urged viewers not to watch it.

Nineteen-year-old Angus T. Jones has been on the show since he was 10 but says he doesn't want to be on it. He says, "Please stop watching it. Please stop filling your head with filth."

The video was posted by the Forerunner Christian Church in California, where Jones says he went to meet his spiritual needs.

Show producer Warner Bros. Television has no comment. CBS hasn't responded to a request for comment left Monday.

The show stars Jon Cryer as Jones' uptight dad and originally featured Charlie Sheen as his hedonistic philandering uncle, but Sheen was replaced by Ashton Kutcher.

Read More..

Amid Hurricane Sandy, a Race to Get a Liver Transplant

It was the best possible news, at the worst possible time.

The phone call from the hospital brought the message that Dolores and Vin Dreeland had long hoped for, ever since their daughter Natalia, 4, had been put on the waiting list for a liver transplant. The time had come.

They bundled her into the car for the 50-mile trip from their home in Long Valley, N.J., to NewYork-Presbyterian Morgan Stanley Children’s Hospital in Manhattan. But it soon seemed that this chance to save Natalia’s life might be just out of reach.

The date was Sunday, Oct. 28, and Hurricane Sandy, the worst storm to hit the East Coast in decades, was bearing down on New York. Airports and bridges would soon close, but the donated organ was in Nevada, five hours away. The time window in which a plane carrying the liver would be able to land in the region was rapidly closing.

In a hospital room, Natalia watched cartoons. Her parents watched the clock, and the weather. “Our anxiety was through the roof,” Mrs. Dreeland said. “It just made your stomach into knots.”

The Dreelands, who are in their 60s, became Natalia’s foster parents in 2008 when she was 7 months old, and adopted her just before she turned 2. They have another adopted daughter, Dorothy Jane, who is 17.

Natalia is a “smart little cookie” who loves school and dressing up Alice, her favorite doll, her mother said. At age 3, Natalia used the word “discombobulated” correctly, Mr. Dreeland said.

Natalia’s health problems date back several years. Her gallbladder was taken out in 2010, and about half her liver was removed in 2011. The underlying problem was a rare disease, Langerhans cell histiocytosis. It causes a tremendous overgrowth of a type of cell in the immune system and can damage organs. Drugs can sometimes keep it in check, but they did not work for Natalia.

In her case, the disease struck the bile ducts, which led to progressive liver damage. “She would have eventually gone into liver failure,” said Dr. Nadia Ovchinsky, a pediatric liver transplant specialist at NewYork-Presbyterian. “And she demonstrated some signs of early liver failure.”

The only hope was a transplant.

Dr. Tomoaki Kato, Natalia’s surgeon, knew that the liver in Nevada was a perfect match for Natalia in the two criteria that matter most: blood type and size. The deceased donor was 2 years old, and though Natalia is nearly 5, she is small for her age. Scar tissue from her previous operations would have made it very difficult to fit a larger organ into her abdomen.

Though Dr. Kato had considered transplanting part of an adult liver into Natalia, a complete organ from a child would be far better for her. But healthy organs from small children do not often become available, Dr. Kato said. This was a rare opportunity, and he was determined to seize it.

But as the day wore on, the odds for Natalia grew slimmer. The operation in Nevada to remove the liver was delayed several times.

At many hospitals, surgery to remove donor organs is done at the end of the day, after all regularly scheduled operations. The Nevada hospital had a busy surgical schedule that day, made worse by a trauma case that took priority.

At the hospital in New York, Tod Brown, an organ procurement coordinator, had alerted a charter air carrier that a flight from Nevada might be needed. That company in turn contacted West Coast carriers to pick up the donated liver and fly it to New York.

Initially, two carriers agreed, but then backed out. Several other charter companies also declined.

Mr. Brown told Dr. Kato that they might have to decline the organ. Dr. Kato, soft-spoken but relentless, said, “Find somebody who can fly.”

Dr. Kato used to work in Miami, where pilots found ways to bypass hurricanes to deliver organs. Even during Hurricane Katrina, his hospital performed transplants.

“I asked the transplant coordinators to just keep pushing,” he said.

Mr. Brown said, “Dr. Kato knew he was going to get that organ, one way or another.”

As the trajectory of the storm became clearer, one of the West Coast charter companies agreed to attempt the flight. The plan was to land at the airport in Teterboro, N.J. The backup was Newark airport, and the second backup was Albany, from where an ambulance would finish the trip.

The timing was critical: organs deteriorate outside the body, and ideally a liver should be transplanted within 12 hours of being removed.

Early Monday, as the storm whirled offshore, the plane landed at Teterboro. Soon a nurse rushed to tell the Dreelands that she had just seen an ambulance with lights and sirens screech up to the hospital. Someone had jumped out carrying a container.

At about 5 a.m., the couple kissed Natalia and saw her wheeled off to the operating room.

Three weeks later, she is back home, on the mend. The complicated regimen of drugs that transplant patients need is tough on a child, but she is getting through it, her father said.

Recently, Mr. Dreeland said, he found himself weeping uncontrollably during a church service for the family of the child who had died. “Their child gave my child life,” he said.

Though only time will tell, because the histiocytosis appeared limited to Natalia’s bile ducts and had not affected other organs, her doctors say there is a good chance that the transplant has cured her.

Read More..

Stocks end lower after a strong week

Wall Street came back to work after the Thanksgiving weekend and faced leftover worries about the “fiscal cliff” and the European debt crisis. Stocks retreated after one of their best weeks of the year.

The Dow Jones industrial average fell 42.31 points to 12,967.37. The Standard & Poor's 500 index declined 2.86 to 1,406.29. And the Nasdaq composite index managed a 9.93-point increase to 2,976.78.

Utility stocks rose the most, while telecommunications companies fell the most.

The major U.S. economic reports were not due until later in the week, leaving investors to rehash the European debt crisis and talks in Washington over the “cliff” of tax increases and government spending cuts set to take effect Jan. 1.

“The themes seem about as recycled as Thanksgiving turkey,” David Kelly, chief global strategist at JPMorgan Funds, wrote in a note to clients.

He expected a better read on the economy later this week, with reports on consumer confidence on Tuesday and unemployment claims and third-quarter economic growth on Thursday.

Scott Carmack, co-portfolio manager at Leader Capital in Portland, Ore., said the decline Monday was all but inevitable after last week, when the Dow climbed 3.3 percent because of encouraging signs from Washington and good economic news overseas.

That made Monday a good day to cash out on last week's gains, Carmack said, especially because traders aren't sure how the fiscal cliff will affect the market for the rest of the year.

“Monday is a good day to take profits,” Carmack said. “No one was in on Friday, so they're doing it Monday.”

The National Retail Federation reported that 247 million shoppers visited stores and shopping websites during the long Thanksgiving weekend, up 9 percent from a year ago. They spent an average of $423, up 6 percent.

Some worry that the momentum won't last, and that deep discounting will hurt stores. Macy's fell $1.87, or 4.5 percent, to $39.86. Saks dropped 29 cents, or 2.8 percent, to $10.23. Target declined $1.71, or 2.6 percent ,to $62.77.

Abercrombie & Fitch was an exception, rising 21 cents to $44.61.

The cliff cast a pall. A government report released Monday warned that a sudden increase in taxes would crimp the spending of middle class families next year, and some analysts wondered whether families would curb spending before the year is over.

The report, by President Barack Obama's National Economic Council and his Council of Economic Advisers, estimated that a married couple earning between $50,000 and $85,000 with two children would see a $2,200 increase in their taxes.

In Europe, leaders of European Union countries tried to reach a deal to lend more money to debt-crippled Greece. The ministers have failed twice in the last two weeks to reach an agreement to release (euro) 44 billion, or $56.8 billion.

In the U.S., though, “Most of these uncertainties have been with us for quite some time,” Sam Stovall, chief equity strategist at S&P Capital IQ, wrote in a note Monday, “and are now regarded by many as annoyances to resolve rather than obstacles to fear.”

In the bond market, the yield on the 10-year U.S. Treasury note fell 2 percentage points to 1.66 percent from late Friday.

In other stock trading:

— McGraw-Hill announced it would sell its education unit to a private equity firm. The company's stock rose 20 cents, or 0.4 percent, to $51.89.

— Facebook stock jumped $1.94, or 8.1 percent, to $25.94 after a Bernstein analyst upgraded his rating of the company, predicting it will beat revenue expectations for the near future.

Read More..

Graham, King depart from Norquist's anti-tax pledge

Americans for Tax Reform president Grover Norquist explains his anti-tax pledge.

By Morgan Little

November 25, 2012, 12:24 p.m.

Sen. Lindsey Graham (R-S.C.) on Sunday joined the ranks of Republican lawmakers stepping away from Grover Norquist’s famous anti-tax pledge, offering to cut his support for the pledge – with a catch.

“I will violate the pledge for the good of the country only if Democrats will do entitlement reform,” he said on ABC’s “This Week,” adding that “the only pledge we should be making to each other is to avoid being Greece.”

Graham specified that although he agrees with Norquist's stand against raising tax rates and not raising taxes for wealthy Americans, he disagrees with him on deduction caps and buying down debt.

';



jQuery(document).ready(function(){
jQuery('#story-body-text').append(littlesig);
});

Photos: 2016 presidential possibilities

McCain softens opposition to Rice, open to Benghazi explanation

Can the bozos who created the 'fiscal cliff' save us from it?

Obama for America weighs in on 'fiscal cliff,' hints at future role

George H.W. Bush: 'Who the hell is Grover Norquist?'

See more stories »

Graham was accompanied by Rep. Peter King (R-N.Y.), who said that “the world has changed,” and sticking to the pledge was a non-starter.

PHOTOS: 2016 presidential possibilities

“If I were in Congress in 1941, I would have signed a declaration of war against Japan. I’m not going to attack Japan today,” he said, asserting that pledges should apply only to the era in which they are signed.

Nonetheless, King remained confident that House Speaker John A. Boehner would do “everything he can to avoid raising tax rates” during negotiations with Democrats.

Norquist’s “Taxpayer Protection Pledge” has been a calling card for Republicans, and a sticking point for Democrats, since its inception in 1986. It calls for the signer to oppose “any and all efforts” to increase tax rates, and to oppose the reduction or elimination of deductions or credits, unless those reductions are met with tax-rate cutbacks.

Graham and King joined Sen. Saxby Chambliss (R-Ga.), who said Wednesday that “I care more about my country than I do about a 20-year-old pledge.”

Chambliss, speaking with Georgia television station WMAZ-TV Channel 13, said he’s ready to “let the political consequences take care of themselves,” setting the stage for Graham and King’s remarks Sunday.

Norquist responded to Chambliss, stating that “his promise is to the people of Georgia."

PHOTOS: President Obama’s past

Norquist also brought attention to a letter Chambliss signed in 2011, promising not to vote for tax increases.

“If he plans to vote for higher taxes to pay for Obama-sized government, he should address the people of Georgia and let them know that he plans to break his promise to them,” Norquist said in a statement, the principles of which also apply to Graham's and King’s comments.

Follow Politics Now on Twitter and Facebook

Read More..

Saudi telco regulator suspends Mobily prepaid sim sales

(Reuters) – Saudi Arabia‘s No.2 telecom operator Etihad Etisalat Co (Mobily) has been suspended from selling pre-paid sim cards by the industry regulator, the firm said in a statement to the kingdom’s bourse on Sunday.

Mobily’s sales of pre-paid, or pay-as-you-go, sim cards will remain halted until the company “fully meets the prepaid service provisioning requirements,” the telco said in the statement.

These requirements include a September order from regulator, Communication and Information Technology Commission (CITC). This states all pre-paid sim users must enter a personal identification number when recharging their accounts and that this number must be the same as the one registered with their mobile operator when the sim card was bought, according to a statement on the CITC website.

This measure is designed to ensure customer account details are kept up to date, the CITC said.

Mobily said the financial impact of the CITC’s decision would be “insignificant”, claiming data, corporate and postpaid revenues would meet its main growth drivers.

The firm, which competes with Saudi Telecom Co (STC) and Zain Saudi, reported a 23 percent rise in third-quarter profit in October, beating forecasts.

Prepaid mobile subscriptions are typically more popular among middle and lower income groups, with telecom operators pushing customers to shift to monthly contracts that include a data allowance.

Customers on monthly, or postpaid, contracts are also less likely to switch provider, but the bulk of customers remain on pre-paid accounts.

Mobily shares were trading down 1.4 percent at 0820 GMT on the Saudi bourse.

(Reporting by Matt Smith; Editing by Dinesh Nair)

Tech News Headlines – Yahoo! News

Read More..

'Twilight,' Bond, 'Lincoln' lead record weekend

LOS ANGELES (AP) — Bella Swan, James Bond and Abe Lincoln have combined to lift Hollywood to record Thanksgiving revenue at the box office.

Kristen Stewart's finale as Bella in "The Twilight Saga: Breaking Dawn — Part 2" was No. 1 again with $64 million during the five-day holiday stretch that began Wednesday, according to studio estimates Sunday.

Daniel Craig's Bond adventure "Skyfall" came in at No. 2 with $51 million, while Daniel Day-Lewis and Steven Spielberg's Civil War saga "Lincoln" finished third with $34.1 million.

According to box-office tracker Hollywood.com, the three films paced Hollywood to an all-time Thanksgiving week best of about $290 million from Wednesday to Sunday.

That tops the previous record of $273 million over Thanksgiving in 2009, when "The Twilight Saga: New Moon" led the weekend.

This Thanksgiving also was a huge 25 percent jump from a year ago, when domestic revenues were a weak $232 million as some big holiday releases fizzled.

With a strong December lineup ahead, Hollywood has resumed its record revenue pace for the year after a brief box-office lull in late summer and early fall.

Domestic revenues for 2012 are at $9.75 billion, putting Hollywood potentially on track for its first $11 billion year, which would beat the 2009 record of $10.6 billion, said Hollywood.com analyst Paul Dergarabedian.

"We're barreling toward a record-breaking box-office year," Dergarabedian said. "It's built on the back of just a lot of really strong movies that have come out over the past few weekends. It bodes very well for the rest of the holidays."

The "Twilight" finale, "Skyfall" and "Lincoln" finished in the same top-three rankings for the second-straight weekend as new releases were unable to dislodge the holdovers.

Released by Lionsgate's Summit Entertainment banner, "Breaking Dawn — Part 2," pulled in $43.1 million from Friday to Sunday, raising its domestic total to $227 million. The movie added $97.4 million overseas to bring its international total to $350.8 million and its worldwide take to $577.7 million.

Sony's "Skyfall" also topped $200 million domestically, ringing up $36 million for the three-day weekend to put its U.S. total at $221.7 million. With $41.3 million more overseas, "Skyfall" raised its international revenues to $568.4 million and its worldwide sales to $790.1 million.

"Lincoln," a DreamWorks film distributed by Disney, took in $25 million over the weekend to lift its domestic revenue to $62.2 million.

Leading the newcomers was Paramount and DreamWorks Animation's tale "Rise of the Guardians" at No. 4 with $24 million for the weekend and $32.6 million since opening Wednesday.

Based on William Joyce's "Guardians of Childhood" books, "Rise of the Guardians" gathers Santa Claus, the Easter Bunny, the Tooth Fairy and other mythical beings as a team of heroes battling an evil overlord.

Close behind at No. 5 was director Ang Lee's shipwreck saga "Life of Pi" at No. 5 with $22 million over the weekend. The 20th Century Fox release has taken in $30.2 million domestically since its Wednesday debut and added $17.5 million in four Asian markets.

"Life of Pi" was adapted from Yann Martel's best-selling novel about an Indian youth adrift on a lifeboat with a Bengal tiger. Many fans considered the introspective novel impossible to film, but Lee has charmed audiences and critics with an inspiring survival story told through dazzling 3-D images.

The weekend's other new wide release, a remake of the 1980s U.S.-invasion tale "Red Dawn," opened at No. 7 with $14.6 million, raising its total to $22 million since debuting Wednesday.

"Red Dawn" sat on the shelf for three years while studio backer MGM went through bankruptcy, with distributor FilmDistrict eventually picking it up for domestic release. The movie's cast includes Chris Hemsworth ("Thor") and Josh Hutcherson ("The Hunger Games") in a story of young guerrillas battling North Korean invaders.

In limited release, Fox Searchlight's "Hitchcock" opened solidly with about $300,000 in 17 theaters. The movie stars Anthony Hopkins as Alfred Hitchcock in a behind-the-scenes story of the making of "Psycho."

The weekend's overall strength came from a broad range of films that clicked with various audiences, from action and family fare to thoughtful drama.

"This is a marketplace that has something for everyone," said Chris Aronson, head of distribution for 20th Century Fox. "You have something deeper like 'Life of Pi,' yet you have a very successful sequel in 'Twilight' at the same time. Adult bio-drama, if you will, in 'Lincoln,' and you have Bond. That's the secret to a very successful and balanced marketplace."

Estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Hollywood.com. Where available, latest international numbers are also included. Final domestic figures will be released Monday.

1. "The Twilight Saga: Breaking Dawn — Part 2," $43.1 million ($97.4 million international).

2. "Skyfall," $36 million ($41.3 million international).

3. "Lincoln," $25 million.

4. "Rise of the Guardians," $24 million ($10 million international).

5. "Life of Pi," $22 million ($17.5 million international)

6. "Wreck-It Ralph," $16.8 million ($2.1 million international).

7. "Red Dawn," $14.6 million.

8. "Flight," $8.6 million ($723,000 international).

9. "Silver Linings Playbook," $4.6 million ($1.6 million international).

10. "Argo," $3.9 million ($6 million international).

___

Estimated weekend ticket sales at international theaters (excluding the U.S. and Canada) for films distributed overseas by Hollywood studios, according to Rentrak:

1. "The Twilight Saga: Breaking Dawn — Part 2," $97.4 million.

2. "Skyfall," $41.3 million.

3. "Life of Pi," $17.5 million.

4. "Rise of the Guardians," $10 million.

5. "Argo," $6 million.

6. "Hotel Transylvania," $5.5 million.

7. "A Werewolf Boy," $4.2 million.

8 (tie). "Don't Cry, Mommy," $3.6 million.

8 (tie). "Evangelion: 3.0 You Can (Not) Redo," $3.6 million.

10. "Wreck-It Ralph," $2.1 million.

___

Online:

http://www.hollywood.com

http://www.rentrak.com

___

Universal and Focus are owned by NBC Universal, a unit of Comcast Corp.; Sony, Columbia, Sony Screen Gems and Sony Pictures Classics are units of Sony Corp.; Paramount is owned by Viacom Inc.; Disney, Pixar and Marvel are owned by The Walt Disney Co.; Miramax is owned by Filmyard Holdings LLC; 20th Century Fox and Fox Searchlight are owned by News Corp.; Warner Bros. and New Line are units of Time Warner Inc.; MGM is owned by a group of former creditors including Highland Capital, Anchorage Advisors and Carl Icahn; Lionsgate is owned by Lions Gate Entertainment Corp.; IFC is owned by AMC Networks Inc.; Rogue is owned by Relativity Media LLC.

Read More..

M.I.T. Lab Hatches Ideas, and Companies, by the Dozens

HOW do you take particles in a test tube, or components in a tiny chip, and turn them into a $100 million company?

Dr. Robert Langer, 64, knows how. Since the 1980s, his Langer Lab at the Massachusetts Institute of Technology has spun out companies whose products treat cancer, diabetes, heart disease and schizophrenia, among other diseases, and even thicken hair.

The Langer Lab is on the front lines of turning discoveries made in the lab into a range of drugs and drug delivery systems. Without this kind of technology transfer, the thinking goes, scientific discoveries might well sit on the shelf, stifling innovation.

A chemical engineer by training, Dr. Langer has helped start 25 companies and has 811 patents, issued or pending, to his name. That’s not too far behind Thomas Edison, who had 1,093. More than 250 companies have licensed or sublicensed Langer Lab patents.

Polaris Venture Partners, a Boston venture capital firm, has invested $220 million in 18 Langer Lab-inspired businesses. Combined, these businesses have improved the health of many millions of people, says Terry McGuire, co-founder of Polaris.

Along the way, Dr. Langer and his lab, including about 60 postdoctoral and graduate students at a time, have found a way to navigate some slippery territory: the intersection of academic research and the commercial market.

Over the last 30 years, many universities — including M.I.T. — have set up licensing offices that oversee the transfer of scientific discoveries to companies. These offices have become a major pathway for universities seeking to put their research to practical use, not to mention add to their revenue streams.

In the sciences in particular, technology transfer has become a key way to bring drugs and other treatments to market. “The model of biomedical innovation relies on research coming out of universities, often funded by public money,” says Josephine Johnston, director of research at the Hastings Center, a bioethics research organization based in Garrison, N.Y.

Just a few of the products that have emerged from the Langer Lab are a small wafer that delivers a dose of chemotherapy used to treat brain cancer; sugar-sequencing tools that can be used to create new drugs like safer and more effective blood thinners; and a miniaturized chip (a form of nanotechnology) that can test for diseases.

The chemotherapy wafer, called the Gliadel, is licensed by Eisai Inc. The company behind the sugar-sequencing tools, Momenta Pharmaceuticals, raised $28.4 million in an initial public offering in 2004. The miniaturized chip is made by T2Biosystems,  which completed a $23 million round of financing in the summer of 2011.

“It’s inconvenient to have to send things to a lab,” so the company is trying to develop more sophisticated methods, says Dr. Ralph Weissleder, a co-founder, with Dr. Langer and others, of T2Biosystems and a professor at Harvard Medical School.

FOR Dr. Langer, starting a company is not the same as it was, say, for Mark Zuckerberg with Facebook. “Bob is not consumed with any one company,” says H. Kent Bowen, an emeritus professor of business administration at Harvard Business School who wrote a case study on the Langer Lab. “His mission is to create the idea.”

Dr. Bowen observes that there are many other academic laboratories, including highly productive ones, but that the Langer Lab’s combination of people, spun-out companies and publications sets it apart. He says Dr. Langer “walks into the great unknown and then makes these discoveries.”

Dr. Langer is well known for his mentoring abilities. He is “notorious for replying to e-mail in two minutes, whether it’s a lowly graduate school student or the president of the United States,” says Paulina Hill, who worked in his lab from 2009 to 2011 and is now a senior associate at Polaris Venture Partners. (According to Dr. Langer, he has corresponded directly with President Obama about stem cell research and federal funds for the sciences.)

Dr. Langer says he looks at his students “as an extended family,” adding that “I really want them to do well.”

And they have, whether in business or in academia, or a combination of the two. One former student, Ram Sasisekharan, helped found Momenta and now runs his own lab at M.I.T. Ganesh Venkataraman Kaundinya is Momenta’s chief scientific officer and senior vice president for research.

Hongming Chen is vice president of research at Kala Pharmaceuticals. Howard Bernstein is chief scientific officer at Seventh Sense Biosystems, a blood-testing company. Still others have taken jobs in the law or in government.

Dr. Langer says he spends about eight hours a week working on companies that come out of his lab. Of the 25 that he helped start, he serves on the boards of 12 and is an informal adviser to 4. All of his entrepreneurial activity, which includes some equity stakes, has made him a millionaire. But he says he is mainly motivated by a desire to improve people’s health.

Operating from the sixth floor of the David H. Koch Institute for Integrative Cancer Research on the M.I.T. campus in Cambridge, Mass., Dr. Langer’s lab has a research budget of more than $10 million for 2012, coming mostly from federal sources.

The research in labs like Dr. Langer’s is eyed closely by pharmaceutical companies. While drug companies employ huge research and development teams, they may not be as freewheeling and nimble, Dr. Langer says. The basis for many long-range discoveries has “come out of academia, including gene therapy, gene sequencing and tissue engineering,” he says.

He has served as a consultant to pharmaceutical companies. Their large size, he says, can end up being an impediment.

“Very often when you are going for real innovation,” he says, “you have to go against prevailing wisdom, and it’s hard to go against prevailing wisdom when there are people who have been there for a long time and you have some vice president who says, ‘No, that doesn’t make sense.’ ”

Pharmaceutical companies are eager to tap into the talent at leading research universities. In 2008, for example, Washington University in St. Louis announced a $25 million pact with Pfizer to collaborate more closely on biomedical research.

But in some situations, the close — critics might say cozy — ties between business and academia have the potential to create conflicts of interest.

There was a controversy earlier this year when it was revealed that the president of the University of Texas M.D. Anderson Cancer Center owned stock in Aveo Oncology, which had announced earlier that the university would be leading clinical trials of one of its cancer drugs.  Last month, the University of Texas announced that he would be allowed to keep his ties with three pharmaceutical companies, including Aveo Oncology; his holdings will be placed in a blind trust.

Read More..

L.A. Auto Show to serve as stage for vehicles, technologies

On any Saturday afternoon, the unlikely mix of exotic coupes, vintage woodies and electric cars sharing Pacific Coast Highway makes clear why Southern California is the center of U.S. car culture.

A similarly diverse array of machinery has made the Los Angeles Auto Show the premier stage for both cutting-edge green cars and sportier offerings designed to carve up that famous coastal road.

This year's show, the first North American showcase of the model year, starts Wednesday for the media and opens to the public Friday at the downtown convention center. It will feature two dozen world debuts, including Porsche's redesigned 2014 Cayman sports car, a hardtop counterpart to the Boxster convertible; and Toyota Motor Corp.'s latest RAV-4, a leading small sport utility vehicle.

Video chat: What's new at the Los Angeles Auto Show

Acura will unveil an all-new flagship sedan, powered by a 3.5-liter V-6 engine making 310 horsepower. Hyundai Motor Co. will show off a special concept car it says was designed with California car culture front of mind.

On the electric front, Chevrolet will reveal its Spark EV, which will have more power, torque and speed than the gas-powered version of the same car. General Motors Co. says the car will jump from a start to 60 mph in less than 8 seconds, which will make it one of the fastest EVs on the market (though still slow compared with the pricier, made-in-California Tesla Model S). Likewise, Fiat will show off an electric version of its 500 mini-car.

If you go to the show, or just want to track the latest in the auto industry, here are five new technologies to watch.

Three-cylinder engines

They have been tried before in America with little success. But a new generation of small, powerful engines will soon make inroads in cars that have traditionally needed at least a four-banger.

Ford Motor Co. will show off its small Fiesta with a new turbocharged three-cylinder engine that produces 123 horsepower and 148 pound-feet of torque — more powerful than the car's current base four-cylinder. The car may also achieve fuel economy north of 40 mpg.

Shrinking the engine size and weight without losing power is a key goal of automotive engineering, said Andrew Fraser, one of the Ford engineers who developed the power plant.

"It's a virtuous circle," Fraser said. "As you reduce the weight of the engine, everything else on the vehicle can be lighter, and you get better weight distribution and it drives better. Resistance to turning the car is largely determined by the weight in the front of it."

That's why many high-end sports cars have a mid-engine, he said, and why 50-50 weight distribution is seen as the holy grail of car design, creating nimble handling.

Other manufacturers — including BMW and Volkswagen — are working with three-cylinder engines that they may introduce in the U.S. market in coming years. The three-cylinder Ford Fiesta goes on sale in the U.S. in the second half of next year.

Phone navigation

Automakers typically embed features such as navigation and voice recognition in dashboards so they can charge as much as $2,000 for the options. Chevrolet is taking a different approach with its smallest and least expensive cars, the Spark and the Sonic.

These vehicles come with a 7-inch color touch screen and GM's MyLink, which allows drivers to purchase a $50 BringGo smartphone app to display a navigation program and traffic updates. This has virtually all of the information drivers would find in an embedded navigation system, including emergency information for police and the nearest hospital, points of interest, maps and turn-by-turn directions.

The MyLink system enables car owners to bring other apps to the vehicle such as Pandora and Stitcher radio services.

"This makes the car an extension of your smartphone," said Sara LeBlanc, global program manager for Chevrolet and General Motors infotainment. "It is an incredible deal when compared to the cost of an aftermarket Garmin or embedded navigation system."

So why don't automakers do this with all of their cars?

Read More..

Black Friday online sales up nearly 21%

Online shoppers avoided long lines like this and boosted Web sales nearly 21%. (Michael Robinson Chavez / Los Angeles Times)

By Shan Li

November 24, 2012, 11:04 a.m.

Black Friday shoppers headed to their laptops, tablet computers and mobile phones to scoop up deals.

On the day after Thanksgiving, traditionally the kickoff to the holiday shopping season, online sales jumped 20.7% over last year, according to study from IBM. That beat the 17.4% growth over Thanksgiving in Web sales.

That reflects a trend that has swept through the retail industry as shoppers increasingly go online to find the best bargains and deals, forcing traditional brick-and-mortar retailers to adapt in in order to retain customers.

Many consumers chose to shop on their mobile devices, with nearly a quarter of shoppers checking out retailers online.

The Apple iPad was top choice for online buyers, comprising almost 10% of total Web shopping. That's followed by the iPhone at 8.7% and Android-powered devices at 5.5%.

"This year's holiday shopper was hungry for great deals and retailers didn't disappoint, said Jay Henderson, strategy director at IBM Smarter Commerce.

ALSO:

Black Friday shoppers smash door at Urban Outfitters

Nine protesters arrested outside Wal-Mart in Paramount

Drivers, beware: Parking lot accidents increase on Black Friday

Follow Shan Li on Twitter @ShanLi

Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.

';
shareDiv.innerHTML = templateHTML;

/* append the new div to the end of the document, which is hidden already with CSS */
document.body.appendChild(shareDiv);

/* Store the div in both a regular JavaScript variable and as a jQuery object so we can reference them faster later */
var shareTip = document.getElementById('shareTip'),
$shareTip = $('#shareTip');

/* This extends our settings object with any user-defined settings passed to the function and returns the jQuery object shareTip
was called on */
return this.each(function() {
if (options) {
$.extend(settings, options);
}

/* This is a hack to make sure the shareTip always fades back to 100% opacity */
var checkOpacity = function (){
if ( $shareTip.css('opacity') !== 1 ){
$shareTip.css({'opacity': 1});
}
};

/* Function that replaces the HTML in the shareTip with the template we defined at the top */
/* It will wipe/reset the links on the social media buttons each time the function is called */
var removeLinks = function (){
shareTip.innerHTML = templateHTML;
};

/* This is the function that makes the links for the Tweet / Share functionality */

var makeURLS = function (link, message){
/* Here we construct the Tweet URL using an array, with values passed to the function */
var tweetConstruct = [
'http://twitter.com/share?url=', link, '&text=', message, '&via=', settings.twitter_account
],
/* Then join the array into one chunk of HTML */
tweetURL = tweetConstruct.join(''),

/* Same story for Facebook */
fbConstruct = [
'http://www.facebook.com/sharer.php?u=', link, '&src=sp'
],

fbURL = fbConstruct.join(''),

newHTML = [
''
],
shareHTML = newHTML.join('');
/* Load in our new HTML */
shareTip.innerHTML = shareHTML;
};

/* Since the shareTip will automatically fade out when the user mouses out of an element */
/* we have to specifically tell the shareTip we want it to stay put when the user mouses over it */
/* This effectively gives the user a 500 ms (or whatever) window to mouse */
/* from the element to the shareTip to prevent it from popping out */
$shareTip.hover(function(){
$shareTip.stop(true, true);
$shareTip.show();
checkOpacity();
}, function(){
$(this).fadeOut(settings.speed);
});

/* This function handles the hover action */
$(this).hover(function(){
/* remove the old links, so someone doesn't accidentally click on them */
removeLinks();

/* If there's already an animation running on the shareTip, stop it */
$shareTip.stop(true, true);

var eso = $(this),
message,
/* Store the width and height of the shareTip and the offset of the element for our calculations */
height = eso.height(),
width = eso.width(),
offset = eso.offset(),
link;


link = eso.children('a').attr('href');
message = escape( eso.find('img').attr('alt') ) || eso.attr(settings.message_attr);

if (link.search('http://') === -1){
link = 'http://www.latimes.com' + link;
}
link = encodeURIComponent(link);

/* If it's at the top of the page, the shareTip will pop under the element */
if (offset.top

Read More..